June 16, 1989 |
G. D. Searle & Co. has agreed to settle all claims and lawsuits over alleged injury from the use of its Copper-7 contraceptive device that were brought by a law firm representing more than 100 such clients, a company spokeswoman said Thursday. Searle spokeswoman Kay Bruno said the agreement, which still requires approval from clients represented by the Minneapolis law firm of Robins, Kaplan, Miller and Ciresi of Minneapolis, bars disclosure of the settlement's terms and conditions, including the number of claims settled.
CALIFORNIA | LOCAL
January 19, 1989 |
A senior federal judge in Los Angeles has declared a mistrial in a major product liability case against G.D. Searle & Co., asserting that the acrimonious proceedings were keeping him awake nights and threatening to give him ulcers. U.S.
December 28, 1988
The Food and Drug Administration announced approval of a new prescription drug it said can prevent stomach ulcers that afflict some of the millions of people who take medicine for arthritis. To be marketed under the trade name Cytotec by G. D. Searle of Skokie, Ill., the drug--misoprostol--is to be labeled for use in patients at high risk for developing complications of stomach ulcers while on arthritis drugs. That would include the elderly and patients of any age with another serious illness.